Sun Pharma has agreed to commercialise a skincare product in the US via an in-licensing agreement

Sun Pharmaceutical Industries NSE -2.54 percent, based in Mumbai, has inked an in-licensing deal with Cassiopea SpA, an Italian pharmaceutical business, to commercialise Winlevi (clascoterone cream 1% ) in the United States... Read more »

Antibody levels to Pfizer and AstraZeneca vaccines may fall after 2-3 months, according to a Lancet study

According to a study published in The Lancet journal, total antibody levels begin to decline six weeks following complete vaccination with Pfizer NSE 4.16 percent and AstraZeneca NSE -0.49 percent vaccines, and... Read more »

EU regulator backs AstraZeneca drug for rare blood disorder in children

AstraZeneca said on Monday the European Medicines Agency (EMA) recommended approving a medicine from its U.S.-based Alexion unit for treating a rare, deadly blood disorder in children and adolescents aged up to... Read more »
Ministry of Ayush

Apex Laboratories receive Government of India regulatory approval for Oral Antiviral Clevira Tablets, as a supporting measure for mild to moderate COVID-19 conditions

Hyderabad, July 2021: Apex Laboratories Private Limited, a Chennai based pharmaceutical manufacturer and exporter known for Research, Innovation and quality medicines for more than four decades, announced the approval of Antiviral drug Clevira... Read more »

BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG

BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country. BDR... Read more »
biological e

Corbevax, Biological E’s COVID-19 vaccine, expected to be released in September.

Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine ‘Corbevax’ by September-end in India, sources said on Monday. The vaccine being developed by Biological-E is a RBD protein sub-unit... Read more »
zydus cadila

Cadila jab immunogenic, safe, Phase 1 trial data suggests

According to a 48-person phase I study published ahead of print in the Lancet’s EClinicalMedicine journal, the DNA vaccine produced by Indian pharmaceutical company Zydus Cadila was shown to be safe and... Read more »
moderna covid-19 vaccine

Moderna doses not available for India till next year, says report

According to an internal government report, the Indian government’s discussions with US pharmaceutical giant Moderna about including its mRNA technology-based coronavirus disease (Covid-19) vaccine in the country’s vaccine programme may take until... Read more »

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech on Friday, 23 July, announced the termination of its memorandum of understanding (MOU) with Precisa Medicamentos and Envixia Pharmaceuticals to sell its COVID-19 vaccine, Covaxin, in Brazil. The pharmaceutical company... Read more »

Intas inks pact eith Meiji and Dong-A ST to commercialise DMB-3115

Intas Pharmaceuticals concluded the sole licence agreement with Meiji and Socio Dong-A Holdings to market the proposed biosimilitary antibody ustekinumab to treat diseases like plaque psoriasis, Crohn’s disease and ulcerative colitis, according... Read more »